SPC104

Sovaldi (sófosbúvír)

  • Status:
    Veitt
  • Application date:
    18.11.2014
  • Application published:
    15.12.2014
  • Grant published:
    15.4.2016
  • Max expiry date:
    16.7.2029
  • Medicine name:
    Sovaldi - sofosbuvir
  • Medicine for children:
    Yes

Timeline

Today
18.11.2014Application
15.12.2014Publication
15.4.2016Registration
16.7.2029Expires

Marketing license

  • IS authorization number:
    EU/1/13/894/001-002
  • Date:
    6.2.2014
  • Foreign authorization number:
    EU/1/13/894/001-002
  • Date:
    16.1.2014

Owner

  • Name:
    Gilead Pharmasset LLC
  • Address:
    c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents